Equities pulled back broadly, with the Nasdaq Composite down 1.16% to 25,818.69 leading losses, the S&P 500 off 0.45% to 7,503.85, and the Russell 2000 down 0.9%, while the VIX spiked 8.06% to 17.43 as hedging demand picked up. Futures point to further softness into the next session, with Nasdaq futures down 0.73% and Dow futures off 0.86%. Energy (+2.84%) and Health Care (+1.53%) were the standout sectors even as the tape fell, while Technology (-2.39%) dragged hardest. Among single names, IOTR (+34.92%) and SKYQ (+19%) led gainers while FCEL (-19.95%) paced decliners; the day's headlines around Blue Origin's $130B valuation and OpenAI's GPT-5.6 release kept private-tech and AI themes in focus even as public tech underperformed.
The proprietary universe signal shows 39.4% of names skewing bullish (strong buy + buy) against 2,840 stocks tracked, a modest tilt but not overwhelming given sell-side representation of 570 sells and 91 strong sells. Breadth narrowed by 1.6 points versus yesterday, suggesting leadership is thinning even as defensive sectors like Health Care and Energy outperform — a pattern consistent with rotation into safety rather than broad-based risk-on participation.
Strong Buy standouts: JPM · BAC · MRK · PM · UNH · WFC · LIN · ANET · SCHW · CB · MO · CNQ
Strong Sell standouts: GFS · STRL · DY · SITM · DDS · IESC · MOS · FORM · MIR · KLIC · SLBT · DIOD
See full signals →| Ticker | Next Report | In | Last EPS YoY | Last Rev YoY |
|---|---|---|---|---|
| AAPL | 2026-08-22 | 45d | +21.8% | +16.6% |
| TSLA | 2026-09-06 | 60d | +8.3% | +15.8% |
| MSFT | 2026-09-12 | 66d | +23.4% | +18.3% |
| JPM | 2026-09-15 | 69d | +17.2% | +10.0% |
| XOM | 2026-09-17 | 71d | -43.2% | +2.4% |
| AVGO | 2026-09-30 | 84d | +85.4% | +47.9% |
The near-term calendar is light: a handful of IPOs (SYTN, STDN, TP, KFDE with no confirmed dates, plus SKHY on 7/10 and CSQR on 7/16) are on watch, but headline earnings from mega-caps like AAPL, TSLA, and MSFT remain 45+ days out, so no major corporate catalysts are imminent.
The private tape stayed active, with Salesforce Ventures leading an $135M Series A for 8090 and Khosla Ventures backing Scaled Cognition's $100M Series A, while Greenfield Partners, Bain Capital Ventures, and FirstMark rounded out a busy stretch of AI- and enterprise-focused rounds; over a longer window, Andreessen Horowitz remains the most active lead investor with 9 deals totaling $926M.
| Date | Company | Event | Amount | Lead Investor |
|---|---|---|---|---|
| 2026-06-29 | 8090 · AI | Series A $135M led by Salesforce Ventures | $135M | Salesforce Ventures |
| 2026-06-26 | Patronus AI · Artificial Intelligence | Series B $50M led by Greenfield Partners | $50M | Greenfield Partners |
| 2026-06-26 | Hera · Healthcare | Series A $27M led by Bain Capital Ventures | $27M | Bain Capital Ventures |
| 2026-06-26 | Nebulock · Technology | Series A $25M led by FirstMark | $25M | FirstMark |
| 2026-06-26 | Tombot · Health and Wellness | Series A3 $7M led by Caduceus Capital Partners | $7M | Caduceus Capital Partners |
| 2026-06-25 | Scaled Cognition · Artificial Intelligence | Series A $100M led by Khosla Ventures | $100M | Khosla Ventures |
| 2026-06-25 | Sail Research · Technology | Seed and Series A $80M led by Kleiner Perkins | $80M | Kleiner Perkins |
| 2026-06-25 | Oblenio Bio · Biotechnology | Series B $62M led by Pfizer Ventures | $62M | Pfizer Ventures |
Most active lead investors (last 45 days)
Track 1,937 pre-IPO names on Private Companies · browse 280+ investor profiles · live deal tape on Deal Signals.
Educational framework discussion of market conditions — not investment advice or a recommendation to buy or sell any security.
Today's S&P 500 decline of 0.45% looks mild on the surface, but the underlying breadth reading — 39.4% bullish sentiment across the universe, down 1.6 points from yesterday — tells a more nuanced story. When headline indices fall gently but breadth narrows, it often means a smaller group of large-cap names (here, mega-cap Technology at -2.39%) is dictating the index-level move while participation elsewhere thins out. This is different from a broad, healthy risk-on rally where gains are shared across sectors and market caps. Traders use breadth divergence as an early signal of fragility: narrow leadership can persist for a while, but it historically raises the odds of sharper drawdowns if the leading names falter, since fewer stocks are absorbing selling pressure. Pairing breadth data with sector dispersion — like today's split between defensive strength (Energy, Health Care) and cyclical weakness (Industrials, Technology) — gives a fuller picture than the index number alone.